التفاصيل البيبلوغرافية
| العنوان: |
Severity Classification of Limbal Stem Cell Failure Due to Steven Johnson Syndrome in the Light of the Classification Consensus of Limbal Stem Cell Deficiency |
| المؤلفون: |
Akgun, Zeynep, Palamar, Melis, Egrilmez, Sait, Yagci, Ayse, Barut Selver, Ozlem |
| المصدر: |
Eye & Contact Lens: Science & Clinical Practice ; volume 50, issue 4, page 159-162 ; ISSN 1542-2321 |
| بيانات النشر: |
Ovid Technologies (Wolters Kluwer Health) |
| سنة النشر: |
2024 |
| الوصف: |
Objectives: To examine and to understand the limbal stem-cell deficiency (LSCD) because of Steven–Johnson syndrome (SJS) in line with the new classification system for the first time in the literature. Methods: Medical records of patients with LSCD because of SJS were reviewed retrospectively. In addition to demographic data and ophthalmologic or systemic findings, anterior segment photographs of the patients were reviewed retrospectively. Limbal stem-cell deficiency severity was graded according to the classification published by the Limbal Stem Cell Working Group. Results: Twenty-four eyes of 14 patients with eye involvement secondary to SJS were included in the study. The mean age of the patients was 36.09±16.70 (9–58) years and the female-to-male ratio was 11:3. The anterior segment photographs of the patients were evaluated by two independent masked observers. Limbal stem-cell deficiency severity was graded according to the classification published by Deng et al. Corneal opacity was divided into three stages according to the area of involvement. Corneal opacity was classified as Stage I if the central 5 mm region of the cornea was not affected, as Stage II if the central 5 mm region of the cornea was affected, and as Stage III if the entire corneal surface was affected. Limbal involvement was classified as Stage A if it was below 50%, as Stage B if it was between 50% and 100%, and as Stage C if it was 100%. Conclusion: This is the first study in the literature to describe and classify LSCD because of SJS, according to the new LSCD classification. Consistent with the results, LSCD follows a bimodal distribution. Most patients demonstrated severe (Stage III—32.14%) or mild (Stage IA—21.42%) LSCD. |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| DOI: |
10.1097/icl.0000000000001073 |
| DOI: |
10.1097/ICL.0000000000001073 |
| الإتاحة: |
https://doi.org/10.1097/icl.0000000000001073Test |
| رقم الانضمام: |
edsbas.6BEC0F9 |
| قاعدة البيانات: |
BASE |
